TY - JOUR
T1 - Paraneoplastic movement disorders
AU - Mehta, Shyamal H.
AU - Morgan, John C.
AU - Sethi, Kapil D.
PY - 2009/7
Y1 - 2009/7
N2 - Neurologic paraneoplastic syndromes (NPSs) result from damage to the nervous system due to the remote effects of cancer not related to metastasis, infection, or metabolic derangements. NPSs are rare, affecting 1 in 10,000 patients with cancer. Pathogenesis is likely related to the immune mechanisms: normal neural tissue is mistakenly attacked due to the similarity in the onconeural antigens expressed by the tumor cells. Among the various "classic" and other NPSs, this review focuses on paraneoplastic movement disorders, including ataxia due to cerebellar degeneration, stiffperson syndrome, opsoclonus-myoclonus syndrome, chorea, parkinsonism, and tremor. The recently described syndrome of paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis is also included, given that these patients have complex movements such as stereotypies and dyskinesias in addition to psychiatric symptoms, altered sensorium, and other neurologic signs. Although variable, treatment and prognosis of NPSs rely heavily on treatment of the underlying malignancy and immunotherapy.
AB - Neurologic paraneoplastic syndromes (NPSs) result from damage to the nervous system due to the remote effects of cancer not related to metastasis, infection, or metabolic derangements. NPSs are rare, affecting 1 in 10,000 patients with cancer. Pathogenesis is likely related to the immune mechanisms: normal neural tissue is mistakenly attacked due to the similarity in the onconeural antigens expressed by the tumor cells. Among the various "classic" and other NPSs, this review focuses on paraneoplastic movement disorders, including ataxia due to cerebellar degeneration, stiffperson syndrome, opsoclonus-myoclonus syndrome, chorea, parkinsonism, and tremor. The recently described syndrome of paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis is also included, given that these patients have complex movements such as stereotypies and dyskinesias in addition to psychiatric symptoms, altered sensorium, and other neurologic signs. Although variable, treatment and prognosis of NPSs rely heavily on treatment of the underlying malignancy and immunotherapy.
UR - http://www.scopus.com/inward/record.url?scp=67651212140&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67651212140&partnerID=8YFLogxK
U2 - 10.1007/s11910-009-0043-4
DO - 10.1007/s11910-009-0043-4
M3 - Review article
C2 - 19515280
AN - SCOPUS:67651212140
SN - 1528-4042
VL - 9
SP - 285
EP - 291
JO - Current neurology and neuroscience reports
JF - Current neurology and neuroscience reports
IS - 4
ER -